And if at this particular time, you launch, you will be lost somewhere. Rajeev Juneja, Vice Chairman & MD, Mankind Pharma | Q4 FY26 I am not going to tell you that we are going to make a lot of money in India, I will never say that, I actually agree with you, it will be very competitive. Rajeev Nannapaneni, Vice Chairman & CEO, Natco Pharma | Q2 FY26 So why run it anyway
Elderly patients may be more sensitive to the medications effects and may require slower titration or lower maintenance doses, particularly if they have reduced renal function or are at higher risk for dehydration from gastrointestinal adverse effects
GLP-1 weight loss in McKinney ranges widely based on whether the medication is compounded or branded FDA-approved
I have a few patients who are lean-bodied who are on these drugs
GLP-1/glucagon co-agonists: cotadutide and pemvidutide Cotadutide, a GLP-1/glucagon receptor dual agonist with 5:1 potency ratio, improved multiple hepatic parameters in phase 2 trials
GLP-1 medications (short for glucagon-like peptide-1 receptor agonists) mimic the natural GLP-1 hormone your body produces in the gut after eating